Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
developmental toxicity
Type of information:
experimental study planned
Study period:
to be determined by ECHA
Justification for type of information:
The substance is handled in the EU at volumes of 100 - 1000 tons per annum and therefore, data requirements of Annex X of EC regulation 1907/2006 need to be met.
Since no adaptations to the standard testing requirement can be applied, the registrant proposes to perform an teratogenicity study (OECD 414).


NON-CONFIDENTIAL NAME OF SUBSTANCE:
- Name of the substance on which testing is proposed to be carried out: 2-Propyn-1-ol, reaction product with oxirane (1-2.5 mol)

CONSIDERATIONS THAT THE GENERAL ADAPTATION POSSIBILITIES OF ANNEX XI OF THE REACH REGULATION ARE NOT ADEQUATE TO GENERATE THE NECESSARY INFORMATION [please address all points below]:
- Available GLP studies: No GLP study fulfilling the requirements of OECD 414 for the target substance is known to the registrant
- Available non-GLP studies: No non-GLP study fulfilling the requirements of OECD 414 for the target substance is known to the registrant
- Historical human data: No human historical data is known to the registrant
- (Q)SAR: No reliable and adequate (Q)SAR model for this endpoint is known to the registrant.
- In vitro methods: No reliable and adequate in-vitro methods for this endpoint are known to the registrant.
- Weight of evidence: In the absence of the above data, a weight of evidence assessment is not possible.
- Grouping and read-across: No structural analogues with experimental data fulfilling the requirements of OECD 414 for the target substance could be identified by the registrant.
- Substance-tailored exposure driven testing: not applicable
- Approaches in addition to above: not applicable
- Other reasons:not applicable

CONSIDERATIONS THAT THE SPECIFIC ADAPTATION POSSIBILITIES OF ANNEXES VI TO X (AND COLUMN 2 THEREOF) OF THE REACH REGULATION ARE NOT ADEQUATE TO GENERATE THE NECESSARY INFORMATION:
The substance does not meet the criteria of specific adaptation possibilities of Annex VI to X and coloumn 2 thereof.

FURTHER INFORMATION ON TESTING PROPOSAL IN ADDITION TO INFORMATION PROVIDED IN THE MATERIALS AND METHODS SECTION:
- Details on study design / methodology proposed [if relevant]: see justification for study design below

Data source

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 414 (Prenatal Developmental Toxicity Study)
GLP compliance:
yes (incl. QA statement)
Limit test:
no

Test material

Constituent 1
Reference substance name:
Reference substance 002
EC Number:
607-802-5

Test animals

Species:
rat

Administration / exposure

Route of administration:
oral: gavage
Analytical verification of doses or concentrations:
yes
Details on mating procedure:
according to guideline
Duration of treatment / exposure:
according to guideline
Frequency of treatment:
according to guideline
Duration of test:
according to guideline

Results and discussion

Results (fetuses)

Fetal abnormalities

Abnormalities:
not specified

Overall developmental toxicity

Developmental effects observed:
not specified

Applicant's summary and conclusion